Antifouling Zwitterionic Monomers
Model: M2005 (MPC)、M1971 / M3295 (SBMA)、M2359 (CBMA)
Category: Medical Devices
Exhibitor: KM3 SCIENTIFIC CORPORATION
Booth No: M206
Characteristic
TCI provides a comprehensive range of zwitterionic monomers featuring various polymerizable functional groups (e.g., acrylates and methacrylamides) for advanced biomedical materials and Next-Generation Drug Delivery Systems (DDS):
Biomimetic Cell Membrane Structure: Includes cutting-edge biomimetic monomers such as phosphobetaines (MPC), sulfobetaines (SBMA), and carboxybetaines (CBMA), exhibiting excellent biocompatibility.
Exceptional Antifouling Performance: Strongly interacts with water molecules via electrostatic forces and hydrogen bonding to form a highly dense, thermodynamically stable "hydration shell" on material surfaces. This physical barrier effectively prevents the non-specific adsorption of blood proteins, bacteria, and cells, fundamentally reducing thrombosis and foreign-body immune reactions.
Broad Biomedical Applications: Highly suitable for developing advanced antifouling surface coatings for soft contact lenses, cardiovascular stents, hemodialysis membranes, catheters, and long-term implantable sensors.
Empowering Next-Gen Nanocarriers: Can be applied to nanomicelles and drug carriers to impart a "stealth effect," significantly prolonging their blood circulation half-life. Furthermore, monomers like CBMA and CBAA possess active carboxyl sites, allowing for the subsequent conjugation of targeted ligands or anticancer drugs on top of their antifouling properties.
Other Products
Products you may be interested in
Highest Rated Products